TP53 and breast carcinoma: The breast cancer cell line MCF-7 and two non-cancerous cell lines—MRC-5 derived from human fetal lung fibroblasts and C17.2 derived from murine neural progenitor cells—were also included in the screening (TP53 status is shown in Table S3).